InvaGen Pharmaceuticals Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution, USP 500mg due to Leaking Sachets
Cipla has not received any reports of adverse events related to this recall.
- Cipla has not received any reports of adverse events related to this recall.
- The medication is packaged in foil pouches, each containing 500mg of Vigabatrin, and there are 50 foil sealed pouches in a shelf pack.
- The Vigabatrin for Oral Solution, USP 500mg product was distributed nationwide to partnered distributors and consignees.
- Distributors, retailers and consumers in possession of Vigabatrin for Oral Solution, USP 500mg Batch No.